published online ahead of print in 2025, DOI: https://doi.org/10.1556/2054.2024.00429
While an extreme lack of attention to context could lead to unethical experimentation, as occurred in some instances during the first wave of scientific research into psychedelics in the 1950s and 60s (Strauss, de la Salle, Sloshower, & Williams, 2022), more subtle harms in psychedelic clinical trials can arise from methodological imperatives to have clinical trial participants wean off all other forms of treatment, use single dose paradigms to preserve blinding, and minimize psychotherapeutic support and follow up.
While an extreme lack of attention to context could lead to unethical experimentation, as occurred in some instances during the first wave of scientific research into psychedelics in the 1950s and 60s (Hartogsohn 2017), more subtle harms in psychedelic clinical trials can arise from methodological imperatives to have clinical trial participants wean off all other forms of treatment, use single dose paradigms to preserve blinding, and minimize psychotherapeutic support and follow up.
The reference Hartogsohn (2017) is listed in References of the article.
We apologize for the mistake.
The Authors